Cyclosporine A/porous quaternized chitosan microspheres as a novel pulmonary drug delivery system.

Related Articles

Cyclosporine A/porous quaternized chitosan microspheres as a novel pulmonary drug delivery system.

Artif Cells Nanomed Biotechnol. 2018 Apr 24;:1-13

Authors: Yang TT, Wen BF, Liu K, Qin M, Gao YY, Ding DJ, Li WT, Zhang YX, Zhang WF

Abstract
N-[(2-Hydroxyl)-propyl-3-trimethyl ammonium] chitosan chloride (HTCC), a hydrosoluble chitosan derivative, has been extensively investigated as a class of drug delivery vehicles because of its unique features. However the studies on HTCC for pulmonary delivery systems have been rarely conducted. This study aimed to design porous microspheres (MS) containing cyclosporine A (CsA) using HTCC as the carrier. The physicochemical properties and biocompatibility of the MS were evaluated. The in vivo efficacy of MS was evaluated in an asthmatic rat model after pulmonary administration. The results showed that porous MS suitable for inhalation could be readily produced by spray drying method. Optimized porous MS in this study exhibited to be biocompatible and safe to use in the lung, and they were effective in suppression of inflammation in the asthmatic rat model. Above all, our results suggested that HTCC porous MS are promising drug carriers for pulmonary drug delivery.

PMID: 29688042 [PubMed - as supplied by publisher]

from #PM All via ola Kala on Inoreader https://ift.tt/2HuDAl4